Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease

Clinical trial NCT02434718 · COMPLETED

Trial details

NCT number: NCT02434718
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2015-06-24
Primary completion: 2016-12-09
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.